Report cover image

Biologics Outsourcing Market

Publisher Coherent Market Insights
Published May 24, 2023
Length 166 Pages
SKU # CMI18001239

Description

Biologics Outsourcing Market, By Product and Service Type (Product, (Antibodies, Recombinant Proteins, Vaccines, Others), Services, (Cell Development, Process Development, Analytical Testing, cGMP Manufacturing, Others)), By Source (Mammalian, Microbial), By Application (Oncology, Cellular and Gene Therapy, Blood & Blood-Related Products Development, Vaccine Development, Stem Cell Research, Others) By End User (Pharmaceutical Industries, Biotechnology Industries, CDMO), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Biologics are the drugs generated from natural sources including human, animal, or microbial cells and consist of carbohydrates, proteins, or nucleic acids. Moreover, biologics include human cells and tissues, live attenuated microbes, allergenic extracts, cell and gene treatments. Biologics medicines are available for the treatment of disease such as chronic disease, cardiovascular disease, and so on.

Pharmaceutical companies had to outsource different stages of the biologic development and manufacturing process to highly effective service provider organizations due to the fast-paced nature of the biologic industry and the insufficient or absence of internal biologic development and manufacturing capabilities and capacities of biopharmaceutical companies. Major pharmaceutical corporations outsource the production of biologics to contract research organizations, contract manufacturing organizations, and others in order to concentrate on their core competencies while reducing operational costs.

Market Dynamics

Key market players are focused on inorganic strategies such as agreements to strengthen its product portfolio, is expected to drive the growth of global biologics outsourcing market over the forecast period. For instance, in November 2021, GenScript ProBio, a subsidiary of GenScript Biotech Corporation offering end-to-end CDMO services, announced that the company had entered into an agreement for cell line development, drug substance, and drug product manufacturing of therapeutic and diagnostic monoclonal antibodies (mAbs).

Key market players is focused on facility expansion to strengthen the company’s service and product portfolio, is expected to propel the growth of global biologics outsourcing market over the forecast period. For instance, in December 2022, Catalent, Inc. a pharmaceutical company, announced that it is establishing a new biologics analytical center of excellence in Durham, England, within North Carolina’s Research Triangle, to offer comprehensive standalone analytical development and testing for biologic drug modalities, including cell and gene therapies. The company planned to invest up to US$ 40 million to fit the 80,000 square-foot facility with equipment and instrumentation, including automation and digitization capabilities

Key features of the study:
  • This report provides in-depth analysis of the global biologics outsourcing market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biologics outsourcing market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Abzena Ltd. Fujifilm Diosynth Biotechnologies, KBI Biopharma, EirGenix, Inc., Curia Global, Inc., Bionova Scientific, Inc., Boehringer Ingelheim International GmbH., STC Biologics., Abbvie Inc., Avid Bioservices, Inc., Catalent Inc., Emergent, Eurofins Scientific, Genentech, Inc., Genscript Biotech Corporation, JSR Corporation, Lonza, Merck KGaA, Rentschler Biopharma SE.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global biologics outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biologics outsourcing market
Detailed Segmentation:
  • Global Biologics Outsourcing Market, By Product and Service Type:
Product
  • Antibodies
  • Recombinant Proteins
  • Vaccines
  • Others
Services
  • Cell Development
  • Process Development
  • Analytical Testing
  • cGMP Manufacturing
  • Others
  • Global Biologics Outsourcing Market, By Source:
Mammalian

Microbial
  • Global Biologics Outsourcing Market By Application:
Oncology

Cellular and Gene Therapy

Blood & Blood-Related Products Development

Vaccine Development

Stem Cell Research

Others
  • Global Biologics Outsourcing Market By End User:
Pharmaceutical Industries

Biotechnology Industries

CDMO
  • Global Biologics Outsourcing Market, By Region:
North America
  • By Country:
U.S.

Canada

Latin America
  • By Country:
Brazil

Mexico

Argentina

Rest of Latin America

Europe
  • By Country:
Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific
  • By Country:
China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East
  • By Country:
GCC

Israel

Rest of Middle East

Africa
  • By Country/Region:
South Africa

Central Africa

North Africa
  • Company Profiles
Thermo Fisher Scientific Inc.*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
Abzena Ltd.

Fujifilm Diosynth Biotechnologies

KBI Biopharma,

EirGenix, Inc.

Curia Global, Inc.

Bionova Scientific, Inc.

Boehringer Ingelheim International GmbH.

STC Biologics.

Abbvie Inc.

Avid Bioservices, Inc.

Catalent Inc.

Emergent

Eurofins Scientific

Genentech, Inc.

Genscript Biotech Corporation

JSR Corporation

Lonza

Merck KGaA

Rentschler Biopharma SE.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

166 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product and Service Type
Market Snapshot, By Source
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Attractiveness Analysis
Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
Service Cost Analysis
4. Global Biologics Outsourcing Market- Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Biologics Outsourcing Market, By Product and Service Type, 2017 – 2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Product
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Antibodies
Recombinant Proteins
Vaccines
Others
Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Cell Development
Process Development
Analytical Testing
cGMP Manufacturing
Others
6. Global Biologics Outsourcing Market, By Source, 2017 – 2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017–2030
Segment Trends
Mammalian
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Microbial
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
7. Global Biologics Outsourcing Market, By Application, 2017 – 2030, (US$ Billion)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017–2030
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Cellular and Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Blood & Blood-Related Products Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Vaccine Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Stem Cell Research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
8. Global Biologics Outsourcing Market, By End User, 2017 – 2030, (US$ Billion
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segments Trends
Pharmaceutical Industries
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
Biotechnology Industries
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
CDMO
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Billion)
9. Global Biologics Outsourcing Market, By Region, 2017–2030, (US$ Billion)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region, 2017–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product and Service Type, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Billion)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Thermo Fisher Scientific Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Abzena Ltd.
Fujifilm Diosynth Biotechnologies
KBI Biopharma, EirGenix, Inc.
EirGenix, Inc.
Curia Global, Inc.
Bionova Scientific, Inc.
Boehringer Ingelheim International GmbH.
STC Biologics.
Abbvie Inc.
Avid Bioservices, Inc.
Catalent Inc.
Emergent
Eurofins Scientific
Genentech, Inc.
Genscript Biotech Corporation
JSR Corporation
Lonza
Merck KGaA
Rentschler Biopharma SE.
11. Section
Research Methodology
About Us
*Browse 24 market data tables and 34 figures on “Biologics Outsourcing Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us